Tylenol Extra Strength
- Product NDC
- 67751-167
- 11-digit product format
- 677510167
- Labeler code
- 67751
- Product ID
- 67751-167_2385e645-881c-5dd8-e063-6394a90adfab
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Navajo Manufacturing Company Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-09-22
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 67751-167 | 67751-167-04 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 67751-167 | 67751-167-03 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-03 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-02 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-04 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67751-167-01 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-01 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-04 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-03 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 67751-167-02 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-01 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-04 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-03 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 67751-167-02 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-01 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-04 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-03 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 67751-167-02 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 67751-167-03 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 67751-167-03 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 67751-167-03 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tylenol Extra Strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 86b6ac01-3866-4cd8-a1be-9babb6ff311b | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Indexing SPL | Related label |
|---|---|---|---|
| 67751-167-01 | 2024-04-17 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-02 | 2024-04-17 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-03 | 2024-04-17 | 9d75b9cf-e68d-f424-e053-dadaa90a57ce | Tylenol Extra Strength |
| 67751-167-04 | 2024-04-17 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-01 | 2022-01-28 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-02 | 2022-01-28 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-04 | 2022-01-28 | d6a99b39-4b62-a426-e053-dadaa90af4c2 | Tylenol Extra Strength |
| 67751-167-03 | 2020-01-31 | 9d75b9cf-e68d-f424-e053-dadaa90a57ce | Tylenol Extra Strength |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67751-167-01 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 | |
| 67751-167-01 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 6 | |
| 67751-167-02 | Tylenol Extra Strength | 4 in 1 POUCH | TABLET, FILM COATED | 4 | 6 | |
| 67751-167-02 | Tylenol Extra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 | |
| 67751-167-04 | Tylenol Extra Strength | 12 in 1 TRAY | TABLET, FILM COATED | 12 | 6 | |
| 67751-167-04 | Tylenol Extra Strength | 1 in 1 POUCH | TABLET, FILM COATED | 1 | 6 | |
| 67751-167-03 | Tylenol Extra Strength | 12 in 1 TRAY | TABLET, FILM COATED | 12 | 2 | |
| 67751-167-03 | Tylenol Extra Strength | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67751-167 | TYLENOL EXTRA STRENGTH (ACETAMINOPHEN) TABLET, FILM COATED [NAVAJO MANUFACTURING COMPANY INC.] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241004_86b6ac01-3866-4cd8-a1be-9babb6ff311b.zip |
| 67751-167 | TYLENOL EXTRA STRENGTH (ACETAMINOPHEN) TABLET, FILM COATED [NAVAJO MANUFACTURING COMPANY INC.] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240418_65bf1556-f25a-9439-e053-2a91aa0a3194.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Reliever Extra Strength | ACETAMINOPHEN | L.N.K. International, Inc. | 8fed703a-9de2-4c76-a783-fcf004f9b890 | 2026-01-07 | Warnings | M013 |
| Aspirin | ASPIRIN | Amerisource Bergen | c3099892-a8cd-4574-a6f9-041e59e2feae | 2026-01-07 | Warnings | M013 |
| Bactimicina Childrens Pain and Fever | ACETAMINOPHEN | DLC Laboratories, Inc. | bdade270-d813-4178-b594-4951632b6839 | 2026-01-07 | Warnings | M013 |
| Goodmeds Extra Strength Pain Relief PM | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Cabinet Health P.B.C. | 02c60967-46d7-49b7-82be-bc3c5fd36484 | 2026-01-06 | Warnings | M013 |
| Childrens Acetaminophen | ACETAMINOPHEN | ARMY AND AIR FORCE EXCHANGE SERVICE | a73f8217-9eae-4e2a-b29c-7de3861d0e37 | 2026-01-06 | Warnings | M013 |
| Pain Relief Acetaminophen PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Rite Aid Corporation | f77f0120-4042-4b11-ba9c-cd35e1cd0bee | 2026-01-05 | Warnings | M013 |
| Menstrual Relief Maximum Strength | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | United Natural Foods, Inc. dba UNFI | 807598ef-9f03-48df-b076-3ee95ef4b06c | 2026-01-05 | Warnings | M013 |
| Pain Relief Extra Strength, Non-Aspirin | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | 1fb5e871-45fd-46fe-bf73-5192f8316e8e | 2026-01-02 | Warnings | M013 |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Valu Merchandisers Company | 0005aafa-08f8-4990-a54d-cc097195708f | 2026-01-02 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN | Walmart Inc. | 152bb455-da5b-ae13-e063-6394a90acab0 | 2026-01-01 | Warnings | M013 |
| Dr. Cocoa for Children Pain and Fever | ACETAMINOPHEN | Infirst Healthcare Inc. | 486ea294-6d18-a907-e063-6294a90ad284 | 2026-01-01 | Warnings | M013 |
| ED APAP | ACETAMINOPHEN | EDWARDS PHARMACEUTICALS, INC. | f76d5fff-ebea-40f9-aad3-4064a0c863f0 | 2025-12-31 | Warnings | M013 |
| EXTRA STRENGTH PAIN RELIEF | ACETAMINOPHEN | GERI-CARE PHARMACEUTICAL CORP | 99ec63ef-aa28-c2fb-e053-2a95a90a9f6d | 2025-12-31 | Warnings | M013 |
| Puregen Labs Acetaminophen | ACETAMINOPHEN | Advanced Rx LLC | 474580af-f6b0-e440-e063-6394a90aaada | 2025-12-31 | Warnings | M013 |
| Liquid Acetaminophen | ACETAMINOPHEN | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | a7dbd4c0-53eb-4368-917b-1432c09ce6b4 | 2025-12-31 | Warnings | M013 |
| Llorens Care Children Acetaminophen | ACETAMINOPHEN | Llorens Pharmaceutical International Division, Inc. | 2a46d7d2-293b-5024-e063-6294a90a31aa | 2025-12-31 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN CAPSULES 500MG (MINIS-RED OPAQUE) | Walgreens | 3a801457-c5d0-b134-e063-6294a90ac5cb | 2025-12-31 | Warnings | M013 |
| Daytime and Nighttime Severe Cold and Flu combo pack | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Genexa Inc. | 190c7eaf-dcd4-d314-e063-6294a90a6f33 | 2025-12-30 | Warnings | M013 |
| BioElectro Extra Strength Headache Relief | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Genomma Lab USA | 683a0fba-921c-48e7-a391-180c04f0d1c4 | 2025-12-30 | Warnings | M013 |
| Pain Relief PM | ACETAMINOPHEN, DIPHENHYDRAMINE | Pioneer Life Sciences, LLC | 0181af13-da32-4431-be39-c31fdfac9202 | 2025-12-29 | Warnings | M013 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67751-167-01 | 67751016701 | 1 POUCH in 1 CARTON (67751-167-01) / 2 TABLET, FILM COATED in 1 POUCH | 1 pouch | 2016-09-22 | 0000-00-00 | No | No | Current |
| 67751-167-02 | 67751016702 | 1 POUCH in 1 CARTON (67751-167-02) / 4 TABLET, FILM COATED in 1 POUCH | 1 pouch | 2016-09-22 | 0000-00-00 | No | No | Current |
| 67751-167-03 | 67751016703 | 12 in 1 TRAY | Historical | |||||
| 67751-167-04 | 67751016704 | 12 POUCH in 1 TRAY (67751-167-04) > 1 TABLET, FILM COATED in 1 POUCH | 12 pouch | 2016-09-22 | 0000-00-00 | No | No | Current |